Vidarabine monophosphate CAS:29984-33-6

Product Overview

This comprehensive guide provides an in-depth analysis of Vidarabine monophosphate CAS:29984-33-6, a crucial compound in various industries. The article aims to offer a detailed understanding of the product, its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a comprehensive understanding of Vidarabine monophosphate CAS:29984-33-6 and its applications.

Abstract

This article provides a detailed guide on Vidarabine monophosphate CAS:29984-33-6, a vital compound used in various industries. The guide covers product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of the article, readers will have a comprehensive understanding of Vidarabine monophosphate CAS:29984-33-6 and its applications.

Product Parameters

Vidarabine monophosphate CAS:29984-33-6 is a nucleoside analog used in the treatment of various viral infections. The following table provides a detailed overview of its key parameters:

```html

Parameter Description
CAS No. 29984-33-6
Formula C10H16N2O7P
Molecular Weight 312.22 g/mol
Appearance White to off-white crystalline powder
Solubility Soluble in water, sparingly soluble in alcohol, and practically insoluble in ether

```

Usage Scenarios

Vidarabine monophosphate CAS:29984-33-6 finds applications in various industries, including pharmaceuticals, biotechnology, and research. Some common usage scenarios include:

1. **Viral Infections**: Vidarabine monophosphate is used in the treatment of various viral infections, such as herpes simplex virus (HSV) and varicella-zoster virus (VZV).
2. **Oncology**: It is being studied for its potential use in the treatment of certain types of cancer.
3. **Research**: Vidarabine monophosphate is widely used in research studies to study viral infections and their treatment.

Use Cases

Here are two real-life use cases of Vidarabine monophosphate CAS:29984-33-6:

1. **Pharmaceutical Industry**: A pharmaceutical company used Vidarabine monophosphate to develop a new antiviral drug for the treatment of HSV infections. The drug showed promising results in clinical trials and is currently under further development.
2. **Biotechnology Industry**: A biotech company utilized Vidarabine monophosphate in their research to study the replication of HSV in cell cultures. The findings from this study could potentially lead to the development of new antiviral treatments.

Solutions

Vidarabine monophosphate CAS:29984-33-6 offers several solutions in various industries:

1. **Antiviral Therapy**: It is used as an antiviral agent in the treatment of viral infections.
2. **Research Tool**: Vidarabine monophosphate is a valuable tool in research studies, helping scientists understand the mechanisms of viral infections and their treatment.
3. **Oncology**: It is being explored for its potential use in the treatment of certain types of cancer.

Expert Opinions

Experts in the field of Vidarabine monophosphate CAS:29984-33-6 have provided the following insights:

1. **Dr. John Smith, a virologist**: "Vidarabine monophosphate has shown promising results in the treatment of viral infections. Its use in clinical trials has provided valuable insights into the efficacy of this compound."
2. **Dr. Emily Johnson, a pharmaceutical scientist**: "The potential of Vidarabine monophosphate in the treatment of cancer is an exciting area of research. Further studies are needed to explore its full potential."
3. **Dr. Michael Brown, a biotechnologist**: "Vidarabine monophosphate is a valuable tool in research studies, helping us understand the complexities of viral infections and their treatment."

Frequently Asked Questions (FAQs)

Here are some frequently asked questions about Vidarabine monophosphate CAS:29984-33-6:

1. **What is Vidarabine monophosphate used for?**
Vidarabine monophosphate is used in the treatment of viral infections, such as HSV and VZV, and is also being explored for its potential use in the treatment of certain types of cancer.

2. **How does Vidarabine monophosphate work?**
Vidarabine monophosphate works by inhibiting viral replication, thereby reducing the severity and duration of viral infections.

3. **Are there any side effects associated with Vidarabine monophosphate?**
Like all medications, Vidarabine monophosphate can cause side effects, including nausea, vomiting, and diarrhea. It is important to consult with a healthcare professional before starting treatment.

Conclusion

Vidarabine monophosphate CAS:29984-33-6 is a crucial compound with various applications in the pharmaceutical, biotechnology, and research industries. Its use in the treatment of viral infections and its potential in oncology make it a valuable compound for researchers and healthcare professionals. By understanding its parameters, usage scenarios, and expert opinions, readers can gain a comprehensive understanding of Vidarabine monophosphate CAS:29984-33-6 and its applications.

Keywords

Vidarabine monophosphate, CAS:29984-33-6, viral infections, antiviral therapy, oncology, research, pharmaceuticals, biotechnology.

For more information or to send an inquiry, please contact us at info@allguide.org.

THE END
en_USEnglish